June 10, 2021 3pm-4pm CEST
We are glad to announce that our CEO Paola Occhetta is presenting BiomimX® innovative solutions on the occasion of our win for the CrossTheBRIDGE2021.
June 16, 2021 4PM (GMT+2)
The second BiomimX Webinar is on its way, and we’re having a special guest this time! Together with Simona Marzorati, head of Laboratory at Accelera – Part of NMS Group , our COO Roberta Visone will present the potential of uHeart model throughout drug discovery and development.
Don’t miss this! Register here
May 20, 2021
We are very pleased to announce that BiomimX® won first place in the 2021 Cross the Bridge competition called by Camera di Commercio Milano Monza Brianza Lodi, earning a 50.000 € prize to implement its project activities.
April 21, 2021
We are glad to announce that our CEO Paola Occhetta is participating to the Organ-on-a-Chip Symposia Series the 21st of April 2021.
She will talk about our human Osteoarthritic (OA) model uKnee and its potential as a tool for testing efficacy of anti-OA drugs and intra-articular medical devices.
Don’t miss it! Register now.
March 24, 2021 4PM (GMT+1)
Towards the replication of human complexity in vitro, we have developed uBeat® technology which allows to take the first steps to mimic human tissues behavior with an unprecedented precision.
Why not planning your next experimental campaign with something that could give you more flexibility and a better representation of clinical insights?
Learn more about uBeat® technology on our first free webinar.
February 9, 2021
We are glad to announce that our latest study “Micro-electrode channel guide (µECG) technology: an online method for continuous electrical recording in a human beating heart-on-chip” is now on-line on Biofabrication.
In this paper we present a new device capable of monitoring the electrical activity of beating cardiac microtissues, together with a proof-of-concept pharmacological validation.
This work is the result of a great collaboration between Academia (Politecnico di Milano) and Industries (BiomimX® Srl & Accelera Srl).
January 21, 2021 (8 PM CET)
2020 has taught us how crucial is to invest in Research, mostly to reduce technical time for testing drugs and medical devices.
Paola Occhetta, BiomimX CEO, and Marco Rasponi, BiomimX President, will explain how our startup contributes to bring pharmaceutical companies to the market with more efficient therapies in a shorter time, thanks to our innovative technologies.
Don’t miss the episode of STARTUPPER broadcast on Thursday 21st January starting at 8 PM CET on channel 821 Sky.
January 20, 2021 (2.30-3.30 PM CET)
Upcoming webinar! Within the SINERGIA framework we are glad to announce that professor Paul Bourgine will be the first speaker of our webinars series, invited by BiomimX® Srl. Prof. Bourgine’s laboratory targets the development of miniaturized human bone organs (hOssicles) in mice to be used as advanced model of healthy and malignant human hematopoiesis. This talk will first cover how embryonic processes can be harnessed for the engineering of hOssicles. The advantages of the hOssicle approach as opposed to standard in vitro and in vivo models will be discussed.
December 7th-10th , 2020
BiomimX® will partecipate to the Digital Biofit 2020 from December 7th to December 10th 2020. We are looking forward to virtually meet you during the one-to-one partnering event and to take part to this exiting Life Science fair!
July 29th, 2020
We are glad to announce that today our company name, BiomimX®, and our technology name, uBeat®, have both received the trademark registration.
Stefano Piazza, Roberta Visone from BiomimX S.r.l., Simona Marzorati from Accelera and Erika Ferrari from Politecnico di Milano joined the #EUvsVIRUS hackaton, conceiving tha “BeatingCovidOnChip”, an innovative microfluidic platform to speed up the drug screening process for Covid-19 treatments.
#BeatMyCovid to #BeatThemAll!
BiomimX® Srl winner of the prize #DigitalForHealth. Thanks to Consorzio DAFNE for the opportunity!
BiomimX® obtains the SME Instrument phase 1
Thanks to the SME Instrument Phase 1awarded for the project uHeart, BiomimX® will accelerate its way to the market!
Best poster award at the Safety Pharmacology Society 2019 Annual Meeting
In a collaborative project of BiomimX®, Politecnico di Milano and Accelera S.r.l., Roberta Visone was awarded the first place in the 2019 Jr. Investigator Poster Contest at the Safety Pharmacology Society 2019 Annual Meeting. September 23-26, 2019, Barcelona, Spain.
Visone R, Marzorati S, Perego V, Occhetta P, Pesenti E,Rasponi M. “uHeart: a beating heart-on-chip platform for on-line recording of functional 3D cardiac microtissues’ electrical activity”
SINERGIA project (MSCA-ITN-ETN-2019) was financed by EU Commission
BiomimX® is part of the SINERGIA network. SINERGIA aims to provide breakthrough strategies for the implementation of new in vitro preclinical platforms in terms of innovative technologies, biological models and drug screening approaches in the effort of bridging the gap between current, simplistic in vitro cultures and faithful and effective future physiological models. More info here!
BiomimX® receives its third Seal of Excellence H2020 from the European Commission!
BiomimX® won the 3rd prize at the “EIT Joint Grand Final” in Budapest
On 16th November 201, BiomimX® was awarded the third prize in the competition HeadStart Funding, which was created to accelerate products and solutions in SMEs and bring the companies to an investment-ready stage.
BiomimX® receives a new Seal of Excellence H2020 from the European Commission
BiomimX® was awarded the First Prize at the Business Plan Competition at TERMIS 2018!
BiomimX® was awarded the First Prize in the Business Plan Competition in Kyoto, during the 5th World Congress of the Tissue Engineering and Regenerative Medicine International Society (Kyoto, Japan).
BiomimX® in Naples for the European Health Catapult and Headstart regional selection event
BiomimX® participated to the final selection, and it was voted as one of the best 8 Teams in the Headstart program. Besides being awarded a prize money (€35,000), our Team will have the possibility to mature its business plan, negotiation and pitching skills as well as to learn from experts thanks to EIT.
BiomimX® at Lab on a chip Symposium in Basel
BiomimX® will participate to the Lab on a chip Symposium – from molecular assays to organs on a chip organized in Basel by The Royal Society of Chemistry journal Lab on a Chip and ETH Zurich.
BiomimX® receives its first Seal of Excellence H2020 from the European Commission
BiomimX® at Bootcamp of BioInItaly/StartUp Initiative 2018 by Intesa Sanpaolo
BiomimX® has been selected and invited to the training and selection phase of the BioInItaly/StartUp Initiative 2018, in the Biotech track. Intesa Sanpaolo Start-Up Initiative is a comprehensive program aimed at technology start-ups looking for concrete business opportunities: every few months, a rigorous selection and training process leads the best start-ups to high-profile, technology-specific events called Arena Meetings, where they can pitch to international investors and corporations.
SNSF/Innosuisse BRIDGE PoC grant for Knee-on-chip
Paola Occhetta was awarded the SNSF/CIT BRIDGE Proof-of-Concept grant for developing a Knee-on-chip platform to speed up the research for anti-osteoarthritic drugs. She will receive 130,000 Swiss francs in funding to implement her project within a collaboration between University Hospital of Basel and BiomimX®.
BiomimX® at Bioindustry Park thanks to Premio Marzotto
BiomimX® has classified among the 10 finalists of Premio Marzotto 2017 – Dall’idea all’impresa with its uKnee model. With its idea, BiomimX® was awarded with one year of mentoring and incubation at Bioindustry Park, a startup incubator located in Ivrea (Italy). Bioindustry Park, lead by Silvano Fumero, is the ideal location and solution to companies in need of efficiency, quality and image.
BiomimX® was founded after winning StartCup Lombardia 2016, in the category of Life Science & Agrofood with its uBeat® technology.
BiomimX® among 10 finalists of Bioupper 2015
BiomimX® has classified among the 10 finalists of the first edition of Bioupper – Let’s give life to life Startups, the empowerment acceleration program for LifeTech startups organized by Novartis and Fondazione Cariplo.